BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21651353)

  • 21. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
    van der Molen AJ
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
    Hosoya T; Okada H; Horio M; Ohno I; Tamura S; Sugimoto H; Tsushima Y; Hayashi H; Fukuda K; Korogi Y; Yoshifumi N
    Nihon Jinzo Gakkai Shi; 2009; 51(7):839-42. PubMed ID: 19928554
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
    Wang SC
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):305-6. PubMed ID: 18811752
    [No Abstract]   [Full Text] [Related]  

  • 24. MRI evaluation of the liver.
    Beavers KL; Semelka RC
    Semin Liver Dis; 2001 May; 21(2):161-77. PubMed ID: 11436570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging of benign focal liver lesions.
    Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of liver malignancies.
    Ba-Ssalamah A; Fakhrai N; Matzek WK; Herneth AM; Stadler A; Bastati N; Herold CJ; Schima W
    Top Magn Reson Imaging; 2007 Dec; 18(6):445-55. PubMed ID: 18303402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging contrast media for visualization of liver function.
    Yoshinori M; Masaharu M; Yuri H; Sayoko N; Nao S; Makoto H
    Magn Reson Imaging; 2010 Jun; 28(5):708-15. PubMed ID: 20378293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrogenic systemic fibrosis.
    Weinreb JC; Kuo PH
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focus on contrast-associated nephrogenic systemic fibrosis.
    Partain CL
    J Magn Reson Imaging; 2009 Dec; 30(6):1231-2. PubMed ID: 19938033
    [No Abstract]   [Full Text] [Related]  

  • 31. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Bertero M; Bainotti S; Comino A; Formica M; Giordano F; Musso L; Palazzini S; Seia Z
    Eur J Dermatol; 2009; 19(1):73-4. PubMed ID: 19171533
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of magnetic resonance in characterizing focal liver lesions].
    Colagrande S; Bartolozzi A; Tonarelli A
    Radiol Med; 1994 Apr; 87(4):469-81. PubMed ID: 8190931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI of the liver.
    Laing AD; Gibson RN
    J Magn Reson Imaging; 1998; 8(2):337-45. PubMed ID: 9562060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte-specific contrast media: not so simple.
    Trout AT; Towbin AJ; Smith EA; Gupta A; Dillman JR
    Pediatr Radiol; 2018 Aug; 48(9):1245-1255. PubMed ID: 30078050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An approach to pediatric liver MRI.
    Mitchell CL; Vasanawala SS
    AJR Am J Roentgenol; 2011 May; 196(5):W519-26. PubMed ID: 21512040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Magnetic resonance imaging of the liver - Diagnostic possibilities and new applications].
    Stocker D; Reiner C
    Ther Umsch; 2020; 77(2):69-74. PubMed ID: 32633221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in functional and molecular MRI technologies in chronic liver diseases.
    Zhou IY; Catalano OA; Caravan P
    J Hepatol; 2020 Nov; 73(5):1241-1254. PubMed ID: 32585160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the actual role of diagnosis and how to assess it?
    Colli A; Fraquelli M
    J Hepatol; 2009 Apr; 50(4):828-9; author reply 829-30. PubMed ID: 19231007
    [No Abstract]   [Full Text] [Related]  

  • 40. Magnetic resonance imaging of the liver: a review.
    Herédia V; Altun E; Ramalho M; Semelka RC
    Expert Opin Med Diagn; 2007 Oct; 1(2):213-23. PubMed ID: 23489308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.